Biologics as a therapeutic approach for a Th17-mediated severe dermatitis in skin barrier disorders
Por:
Riggioni C, Alvaro-Lozano M and Alsina L
Publicada:
1 nov 2020
Ahead of Print:
1 ago 2020
Resumen:
Filiaciones:
:
Institut de Recerca Sant Joan de Déu, Barcelona, Spain
Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain
Alvaro-Lozano M:
Institut de Recerca Sant Joan de Déu, Barcelona, Spain
Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain
Alsina L:
Universitat de Barcelona, Barcelona, Spain
Institut de Recerca Sant Joan de Déu, Barcelona, Spain
Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain
Clinical Immunology and Primary Immunodeficiencies Unit, Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu Barcelona Spain, Barcelona, Spain
|